BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18179407)

  • 21. Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.
    Brunn A; Montesinos-Rongen M; Strack A; Reifenberger G; Mawrin C; Schaller C; Deckert M
    Acta Neuropathol; 2007 Sep; 114(3):271-6. PubMed ID: 17641901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
    Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
    Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
    Dong W; Xiang J; Li C; Cao Z; Huang Z
    J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
    Kong L; Li Q; Wang L; Liu Z; Sun T
    Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
    Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers.
    Jeffery N; McLean MH; El-Omar EM; Murray GI
    Histopathology; 2009 Jun; 54(7):820-8. PubMed ID: 19635101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of MMP2 and MMP9 expression in prostate cancer].
    Zhang XY; Hong BF; Chen GF; Lu YL; Zhong M
    Zhonghua Nan Ke Xue; 2005 May; 11(5):359-61, 364. PubMed ID: 15934460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of matrix metalloproteinases 1, 2, and 9 in odontogenic myxoma and dental germ papilla.
    Nonaka CF; Augusto Vianna Goulart Filho J; Cristina da Costa Miguel M; Batista de Souza L; Pereira Pinto L
    Pathol Res Pract; 2009; 205(7):458-65. PubMed ID: 19243899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas.
    Kondratiev S; Gnepp DR; Yakirevich E; Sabo E; Annino DJ; Rebeiz E; Laver NV
    Hum Pathol; 2008 Mar; 39(3):337-43. PubMed ID: 18045645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of matrix metalloproteinases and their inhibitors by interferon-beta: a longitudinal study in multiple sclerosis patients.
    Bernal F; Elias B; Hartung HP; Kieseier BC
    Mult Scler; 2009 Jun; 15(6):721-7. PubMed ID: 19383643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic changes of matrix metalloproteinases in rat liver during the development of diethylnitrosamine-induced hepatocarcinoma.
    Gao Y; Zhang Z; Jiang ZS; Fang SG; Sun EW; Wang Y; Chen BH
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):865-8. PubMed ID: 12377602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinase-2 and matrix metalloproteinase-9 expression in canine and feline meningioma.
    Mandara MT; Pavone S; Mandrioli L; Bettini G; Falzone C; Baroni M
    Vet Pathol; 2009 Sep; 46(5):836-45. PubMed ID: 19276056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct patterns of matrix metalloproteinase-2 and -9 expression in normal human cell lines.
    Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
    Oncol Rep; 2009 Mar; 21(3):821-6. PubMed ID: 19212645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
    Yu W; Liu J; Xiong X; Ai Y; Wang H
    Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K; Zen Y; Yamaguchi J; Ohira S; Ishikawa A; Ikeda H; Sato Y; Harada K; Sasaki M; Sasaki M; Sakamoto H; Nagino M; Nimura Y; Ohta T; Nakanuma Y
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
    Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tendon degeneration is not mediated by regulation of Toll-like receptors 2 and 4 in human tenocytes.
    de Mos M; Joosten LA; Oppers-Walgreen B; van Schie JT; Jahr H; van Osch GJ; Verhaar JA
    J Orthop Res; 2009 Aug; 27(8):1043-7. PubMed ID: 19148938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical expression of MMPs 1, 7, and 26 in syndrome and nonsyndrome odontogenic keratocysts.
    Cavalcante RB; Pereira KM; Nonaka CF; Nogueira RL; de Souza LB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):99-105. PubMed ID: 18585626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.